Skip to content
Agentic OS
Menu

Intelligence / Healthtech / Device Recalls / Siemens Healthcare Diagnostics, INC.

QualityClass II recall26 Aug 2026

Siemens Healthcare Diagnostics, INC.

26 Aug 2026: Class II recall · Syva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL, 1x14mL. Recorded in the openFDA device enforcement reports.

View the source record

Reported
26 Aug 2026
Recall Class
Class II
Product
Syva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL, 1x14mL
Reason
Due to unacceptable precision performance exhibited in certain lots of the Emit 2000 Quinidine Assay, which may lead to erroneously elevated quinidine measurements, creating risk of sub-optimal patient treatment, including potential life-th
Country
United States
Status
Ongoing
Reference
Z-2975-2026
Location
East Walpole, MA
What this signal means

A recall puts quality, regulatory, field service and communications under pressure at once.

  1. Class II leads with 660 of 741, then Class I (68).
  2. 235 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Siemens Healthcare Diagnostics, INC.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this quality signal, for your approval.

Start free

Across AOS Research

Other records for Siemens Healthcare Diagnostics, INC. in our registers.

More in Class II

Device Recalls

See all

Source: openFDA device enforcement reports, data to 18 Nov 2026. Device recalls classified by FDA, by report date. Class I is the most serious. AOS shows what the public record says; it does not verify or endorse the company.